Beyond the landmark 2007 study, the broader body of evidence supporting GHK-Cu for hair includes: Follicle enlargement studies: Multiple in vitro studies confirm GHK-Cu increases the size of hair follicles, reversing miniaturization the key driver of visible thinning in androgenetic alopecia Anagen phase extension: Research confirms GHK-Cu extends the active growth phase of follicles, producing longer, thicker hairs per growth cycle Minoxidil comparison: Some studies suggest GHK-Cu performs comparably to 5% Minoxidil for hair growth stimulation through a more targeted, follicle-specific mechanism with a significantly better side effect profile Wound healing evidence: GHK-Cu's extensive wound healing evidence (accelerating tissue repair by 3040%) is directly relevant to scalp health the same repair mechanisms that heal damaged skin also support follicle recovery from inflammation and miniaturization damage Anti-inflammatory scalp research: GHK-Cu's consistent anti-inflammatory effects in skin tissue translate directly to scalp applications reducing the follicle-damaging inflammation that accelerates hair loss GHK-Cu vs Minoxidil: The Honest Comparison GHK-Cu and Minoxidil work through complementary mechanisms Minoxidil primarily through vasodilation, GHK-Cu primarily through direct follicle cell stimulation and anti-inflammatory action

They carry meaningful safety, regulatory, or long-term unknown risk profiles, and we prefer to work with peptides that have a more defined clinical track record and a physician-supervised pathway
However, standard reduced Glutathione (GSH) is often unstable and therefore has low bioavailability when taken orally
MIDDLE EAST GLUTATHIONE MARKET SIZE, BY PHARMACEUTICAL, 2018-2032 (USD MILLION) TABLE 340